The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
The global Rivaroxaban market was valued at US$ 7509 million in 2020 and is expected to reach US$ 12830 million by the end of 2027, growing at a CAGR of 8.2% during 2021-2027.
This report focuses on Rivaroxaban volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Rivaroxaban market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Rivaroxaban Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
2.5 mg
10 mg
15 mg
20 mg
Segment by Application
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bayer
J&J
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
The global Rivaroxaban market was valued at US$ 7509 million in 2020 and is expected to reach US$ 12830 million by the end of 2027, growing at a CAGR of 8.2% during 2021-2027.
This report focuses on Rivaroxaban volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Rivaroxaban market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Rivaroxaban Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
2.5 mg
10 mg
15 mg
20 mg
Segment by Application
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bayer
J&J
Index1 Rivaroxaban Market Overview
1.1 Product Overview and Scope of Rivaroxaban
1.2 Rivaroxaban Segment by Type
1.2.1 Global Rivaroxaban Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5 mg
1.2.3 10 mg
1.2.4 15 mg
1.2.5 20 mg
1.3 Rivaroxaban Segment by Application
1.3.1 Global Rivaroxaban Sales Comparison by Application: (2021-2027)
1.3.2 Acute Coronary Syndrome (ACS)
1.3.3 Venous Thromboembolism (VTE)
1.4 Global Rivaroxaban Market Size Estimates and Forecasts
1.4.1 Global Rivaroxaban Revenue 2016-2027
1.4.2 Global Rivaroxaban Sales 2016-2027
2 Rivaroxaban Market Competition by Manufacturers
2.1 Global Rivaroxaban Sales Market Share by Manufacturers (2016-2021)
2.2 Global Rivaroxaban Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Rivaroxaban Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Rivaroxaban Manufacturing Sites, Area Served, Product Type
2.5 Rivaroxaban Market Competitive Situation and Trends
2.5.1 Rivaroxaban Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Rivaroxaban Players Market Share by Revenue
2.5.3 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rivaroxaban Retrospective Market Scenario by Region
3.1 Global Rivaroxaban Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Rivaroxaban Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Rivaroxaban Market Facts & Figures by Country
3.3.1 North America Rivaroxaban Sales by Country
3.3.2 North America Rivaroxaban Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rivaroxaban Market Facts & Figures by Country
3.4.1 Europe Rivaroxaban Sales by Country
3.4.2 Europe Rivaroxaban Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rivaroxaban Market Facts & Figures by Region
3.5.1 Asia Pacific Rivaroxaban Sales by Region
3.5.2 Asia Pacific Rivaroxaban Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Rivaroxaban Market Facts & Figures by Country
3.6.1 Latin America Rivaroxaban Sales by Country
3.6.2 Latin America Rivaroxaban Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Rivaroxaban Market Facts & Figures by Country
3.7.1 Middle East and Africa Rivaroxaban Sales by Country
3.7.2 Middle East and Africa Rivaroxaban Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Rivaroxaban Historic Market Analysis by Type
4.1 Global Rivaroxaban Sales Market Share by Type (2016-2021)
4.2 Global Rivaroxaban Revenue Market Share by Type (2016-2021)
4.3 Global Rivaroxaban Price by Type (2016-2021)
5 Global Rivaroxaban Historic Market Analysis by Application
5.1 Global Rivaroxaban Sales Market Share by Application (2016-2021)
5.2 Global Rivaroxaban Revenue Market Share by Application (2016-2021)
5.3 Global Rivaroxaban Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer Rivaroxaban Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 J&J
6.2.1 J&J Corporation Information
6.2.2 J&J Description and Business Overview
6.2.3 J&J Rivaroxaban Sales, Revenue and Gross Margin (2016-2021)
6.2.4 J&J Rivaroxaban Product Portfolio
6.2.5 J&J Recent Developments/Updates
7 Rivaroxaban Manufacturing Cost Analysis
7.1 Rivaroxaban Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rivaroxaban
7.4 Rivaroxaban Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rivaroxaban Distributors List
8.3 Rivaroxaban Customers
9 Rivaroxaban Market Dynamics
9.1 Rivaroxaban Industry Trends
9.2 Rivaroxaban Growth Drivers
9.3 Rivaroxaban Market Challenges
9.4 Rivaroxaban Market Restraints
10 Global Market Forecast
10.1 Rivaroxaban Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rivaroxaban by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Rivaroxaban by Type (2022-2027)
10.2 Rivaroxaban Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rivaroxaban by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Rivaroxaban by Application (2022-2027)
10.3 Rivaroxaban Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rivaroxaban by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Rivaroxaban by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rivaroxaban Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Rivaroxaban Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Rivaroxaban Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Rivaroxaban Covered in This Study
Table 5. Global Rivaroxaban Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Rivaroxaban Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Rivaroxaban Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Rivaroxaban Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Rivaroxaban Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Rivaroxaban Manufacturing Sites and Area Served
Table 11. Manufacturers Rivaroxaban Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rivaroxaban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Rivaroxaban Sales by Region (2016-2021) & (M Units)
Table 16. Global Rivaroxaban Sales Market Share by Region (2016-2021)
Table 17. Global Rivaroxaban Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 19. North America Rivaroxaban Sales Market Share by Country (2016-2021)
Table 20. North America Rivaroxaban Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 22. Europe Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 23. Europe Rivaroxaban Sales Market Share by Country (2016-2021)
Table 24. Europe Rivaroxaban Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Rivaroxaban Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Rivaroxaban Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Rivaroxaban Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Rivaroxaban Revenue Market Share by Region (2016-2021)
Table 30. Latin America Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Rivaroxaban Sales Market Share by Country (2016-2021)
Table 32. Latin America Rivaroxaban Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Rivaroxaban Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Rivaroxaban Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 38. Global Rivaroxaban Sales (M Units) by Type (2016-2021)
Table 39. Global Rivaroxaban Sales Market Share by Type (2016-2021)
Table 40. Global Rivaroxaban Revenue (Million US$) by Type (2016-2021)
Table 41. Global Rivaroxaban Revenue Share by Type (2016-2021)
Table 42. Global Rivaroxaban Price (US$/Unit) by Type (2016-2021)
Table 43. Global Rivaroxaban Sales (M Units) by Application (2016-2021)
Table 44. Global Rivaroxaban Sales Market Share by Application (2016-2021)
Table 45. Global Rivaroxaban Revenue (Million US$) by Application (2016-2021)
Table 46. Global Rivaroxaban Revenue Share by Application (2016-2021)
Table 47. Global Rivaroxaban Price (US$/Unit) by Application (2016-2021)
Table 48. Bayer Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Rivaroxaban Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Bayer Rivaroxaban Product
Table 52. Bayer Recent Developments/Updates
Table 53. J&J Corporation Information
Table 54. J&J Description and Business Overview
Table 55. J&J Rivaroxaban Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. J&J Rivaroxaban Product
Table 57. J&J Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Rivaroxaban Distributors List
Table 61. Rivaroxaban Customers List
Table 62. Rivaroxaban Market Trends
Table 63. Rivaroxaban Growth Drivers
Table 64. Rivaroxaban Market Challenges
Table 65. Rivaroxaban Market Restraints
Table 66. Global Rivaroxaban Sales Forecast by Type (2022-2027) & (M Units)
Table 67. Global Rivaroxaban Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Rivaroxaban Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Rivaroxaban Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Rivaroxaban Sales Forecast by Application (2022-2027) & (M Units)
Table 71. Global Rivaroxaban Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Rivaroxaban Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Rivaroxaban Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Rivaroxaban Sales Forecast by Region (2022-2027) & (M Units)
Table 75. Global Rivaroxaban Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Rivaroxaban Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Rivaroxaban Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rivaroxaban
Figure 2. Global Rivaroxaban Market Share by Type in 2020 & 2027
Figure 3. 2.5 mg Product Picture
Figure 4. 10 mg Product Picture
Figure 5. 15 mg Product Picture
Figure 6. 20 mg Product Picture
Figure 7. Global Rivaroxaban Market Share by Application in 2020 & 2027
Figure 8. Acute Coronary Syndrome (ACS)
Figure 9. Venous Thromboembolism (VTE)
Figure 10. Global Rivaroxaban Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rivaroxaban Market Size 2016-2027 (US$ Million)
Figure 12. Global Rivaroxaban Sales 2016-2027 (M Units)
Figure 13. Global Rivaroxaban Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Rivaroxaban Sales Share by Manufacturers in 2020
Figure 15. Global Rivaroxaban Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Rivaroxaban Players: Market Share by Revenue in 2020
Figure 17. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Rivaroxaban Sales Market Share by Region (2016-2021)
Figure 19. Global Rivaroxaban Sales Market Share by Region in 2020
Figure 20. Global Rivaroxaban Revenue Market Share by Region (2016-2021)
Figure 21. Global Rivaroxaban Revenue Market Share by Region in 2020
Figure 22. U.S. Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Rivaroxaban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Rivaroxaban by Type (2016-2021)
Figure 45. Sales Market Share of Rivaroxaban by Application (2016-2021)
Figure 46. Sales Market Share of Rivaroxaban by Application in 2020
Figure 47. Revenue Share of Rivaroxaban by Application (2016-2021)
Figure 48. Revenue Share of Rivaroxaban by Application in 2020
Figure 49. Manufacturing Cost Structure of Rivaroxaban
Figure 50. Manufacturing Process Analysis of Rivaroxaban
Figure 51. Rivaroxaban Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
